Common Stock, Shares, Outstanding of Outlook Therapeutics, Inc. from 30 Sep 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Outlook Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2015 to 31 Dec 2025.
  • Outlook Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 64,556,570, a 159% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Outlook Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 64,556,570 +39,650,935 +159% 31 Dec 2025 10-Q 17 Feb 2026 2026 Q1
Q3 2025 53,887,233 +29,981,598 +125% 30 Sep 2025 10-Q 17 Feb 2026 2026 Q1
Q2 2025 43,479,051 +20,073,414 +86% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q3
Q1 2025 32,907,014 +10,894,187 +49% 31 Mar 2025 10-Q 15 May 2025 2025 Q2
Q4 2024 24,905,635 -235,351,882 -90% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q3 2024 23,905,635 +10,892,802 +84% 30 Sep 2024 10-K 19 Dec 2025 2025 FY
Q2 2024 23,405,637 -235,298,418 -91% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 22,012,827 -234,653,967 -91% 31 Mar 2024 10-Q 15 May 2024 2024 Q2
Q4 2023 260,257,517 +3,590,723 +1.4% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q1
Q3 2023 13,012,833 -214,297,739 -94% 30 Sep 2023 10-K 27 Dec 2024 2024 FY
Q2 2023 258,704,055 +32,761,336 +14% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 256,666,794 +30,874,052 +14% 31 Mar 2023 10-Q 15 May 2023 2023 Q2
Q4 2022 256,666,794 +32,406,192 +14% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q1
Q3 2022 227,310,572 +50,848,944 +29% 30 Sep 2022 10-K 22 Dec 2023 2023 FY
Q2 2022 225,942,719 +51,129,393 +29% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q3
Q1 2022 225,792,742 +52,186,935 +30% 31 Mar 2022 10-Q 13 May 2022 2022 Q2
Q4 2021 224,260,602 +97,077,493 +76% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q1
Q3 2021 176,461,628 +49,278,519 +39% 30 Sep 2021 10-K 29 Dec 2022 2022 FY
Q2 2021 174,813,326 +48,453,262 +38% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 173,605,807 +83,854,615 +93% 31 Mar 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 127,183,109 +88,752,185 +231% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 127,183,109 +98,573,114 +345% 30 Sep 2020 10-K 23 Dec 2021 2021 FY
Q2 2020 126,360,064 +98,127,036 +348% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q1 2020 89,751,192 +77,991,562 +663% 31 Mar 2020 10-Q 15 May 2020 2020 Q2
Q4 2019 38,430,924 -46,660,862 -55% 31 Dec 2019 10-Q 14 Feb 2020 2020 Q1
Q3 2019 28,609,995 +19,582,504 +217% 30 Sep 2019 10-K 23 Dec 2020 2020 FY
Q2 2019 28,233,028 -43,965,440 -61% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q3
Q1 2019 11,759,630 -13,980,828 -54% 31 Mar 2019 10-Q 15 May 2019 2019 Q2
Q4 2018 85,091,786 +59,561,059 +233% 31 Dec 2018 10-Q 14 Feb 2019 2019 Q1
Q3 2018 9,027,491 -15,906,453 -64% 30 Sep 2018 10-K 19 Dec 2019 2019 FY
Q2 2018 72,198,468 +47,539,416 +193% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q3
Q1 2018 25,740,458 +1,640,507 +6.8% 31 Mar 2018 10-Q 15 May 2018 2018 Q2
Q4 2017 25,530,727 +1,942,696 +8.2% 31 Dec 2017 10-Q 14 Feb 2018 2018 Q1
Q3 2017 24,933,944 +2,131,166 +9.3% 30 Sep 2017 10-K 18 Dec 2018 2018 FY
Q2 2017 24,659,052 +24,659,052 30 Jun 2017 10-Q 14 Aug 2017 2017 Q3
Q1 2017 24,099,951 +24,099,951 31 Mar 2017 10-Q 15 May 2017 2017 Q2
Q4 2016 23,588,031 31 Dec 2016 10-Q 14 Feb 2017 2017 Q1
Q3 2016 22,802,778 +13,366,484 +142% 30 Sep 2016 10-K 29 Dec 2017 2017 FY
Q2 2016 0 30 Jun 2016 10-Q 15 Aug 2016 2016 Q3
Q1 2016 0 31 Mar 2016 10-Q 27 Jun 2016 2016 Q2
Q3 2015 9,436,294 30 Sep 2015 10-K 29 Dec 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.